A Multicenter, Double Blind, Placebo Controlled Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis
Phase of Trial: Phase II
Latest Information Update: 28 Sep 2017
At a glance
- Drugs Corticotropin (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Proof of concept; Therapeutic Use
- Acronyms PENNANT
- Sponsors Mallinckrodt LLC
- 22 Sep 2017 Planned End Date changed from 1 Nov 2020 to 1 Mar 2020.
- 22 Sep 2017 Planned primary completion date changed from 1 Dec 2019 to 1 Mar 2020.
- 19 Sep 2017 Planned number of patients changed from 195 to 213.